- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 10.72M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $5.84M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.67M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $12.34M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.14M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $13.11M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $13.77M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $12.28M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $13.7M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $24.44M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $24.91M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 10.77M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $197.26K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $608.77K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $9.52M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $9.37M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.01 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $2.55M |
| Net Income | Q1 2025 · Mar 31, 2024 | $127.41K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$35.84K |
| Revenue | Q1 2025 · Mar 31, 2024 | $4.81M |